初级非药物治疗开角型青光眼的成本效益

Q4 Medicine

Revista Brasileira De Oftalmologia Pub Date : 2023-03-24 DOI:10.37039/1982.8551.20230011

Daniela Marcelo Gravina, Ricardo Augusto Paletta Guedes, A. Chaoubah

{"title":"初级非药物治疗开角型青光眼的成本效益","authors":"Daniela Marcelo Gravina, Ricardo Augusto Paletta Guedes, A. Chaoubah","doi":"10.37039/1982.8551.20230011","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the economic impact of starting the treatment of primary open angle glaucoma with non-pharmacological strategies within the scope of reference centers for the treatment of glaucoma in the Unified Health System. Methods: The population of this study comes from a hypothetical cohort of patients aged 60 years with initial primary open angle glaucoma. The reference strategy (strategy 1) is based only on the use of eye drops","PeriodicalId":49619,"journal":{"name":"Revista Brasileira De Oftalmologia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Custo-utilidade do tratamento primário não farmacológico do glaucoma de ângulo aberto\",\"authors\":\"Daniela Marcelo Gravina, Ricardo Augusto Paletta Guedes, A. Chaoubah\",\"doi\":\"10.37039/1982.8551.20230011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To evaluate the economic impact of starting the treatment of primary open angle glaucoma with non-pharmacological strategies within the scope of reference centers for the treatment of glaucoma in the Unified Health System. Methods: The population of this study comes from a hypothetical cohort of patients aged 60 years with initial primary open angle glaucoma. The reference strategy (strategy 1) is based only on the use of eye drops\",\"PeriodicalId\":49619,\"journal\":{\"name\":\"Revista Brasileira De Oftalmologia\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Brasileira De Oftalmologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37039/1982.8551.20230011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira De Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37039/1982.8551.20230011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Custo-utilidade do tratamento primário não farmacológico do glaucoma de ângulo aberto

Objective: To evaluate the economic impact of starting the treatment of primary open angle glaucoma with non-pharmacological strategies within the scope of reference centers for the treatment of glaucoma in the Unified Health System. Methods: The population of this study comes from a hypothetical cohort of patients aged 60 years with initial primary open angle glaucoma. The reference strategy (strategy 1) is based only on the use of eye drops

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Brasileira De Oftalmologia OPHTHALMOLOGY-

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A Revista Brasileira de Oftalmologia (Rev Bras Oftalmol.) - ISSN 0034-7280, publicação científica da Sociedade Brasileira de Oftalmologia, se propõe a divulgar artigos que contribuam para o aperfeiçoamento e o desenvolvimento da prática, da pesquisa e do ensino da Oftalmologia e de especialidades afins. Todos os manuscritos, após aprovação pelos Editores serão avaliados por dois ou três revisores qualificados (peer review), sendo o anonimato garantido em todo o processo de julgamento.